Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Intangibles: 2022-2024

Historic Intangibles for Arcutis Biotherapeutics (ARQT) over the last 3 years, with Dec 2024 value amounting to $9.5 million.

  • Arcutis Biotherapeutics' Intangibles rose 57.02% to $15.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.4 million, marking a year-over-year increase of 57.02%. This contributed to the annual value of $9.5 million for FY2024, which is 47.24% up from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Intangibles stood at $9.5 million for FY2024, which was up 47.24% from $6.4 million recorded in FY2023.
  • In the past 5 years, Arcutis Biotherapeutics' Intangibles ranged from a high of $9.5 million in FY2024 and a low of $6.4 million during FY2023.
  • Its 3-year average for Intangibles is $7.7 million, with a median of $7.2 million in 2022.
  • As far as peak fluctuations go, Arcutis Biotherapeutics' Intangibles declined by 10.43% in 2023, and later spiked by 47.24% in 2024.
  • Over the past 3 years, Arcutis Biotherapeutics' Intangibles (Yearly) stood at $7.2 million in 2022, then dropped by 10.43% to $6.4 million in 2023, then soared by 47.24% to $9.5 million in 2024.